A Revisit on FDA Approved Anticancer Drugs (1949 – 2024)

Review Article

Abstract

The U.S Food and Drug Administration (FDA) has approved and expanded indications for many drugs related to the treatment of different types of cancer and adverse events. One of the first drugs used clinically in modern medicine for cancer treatment was the alkylating agent mechlorethamine, a nitrogen mustard found effective in treating lymphomas in the 1940s. FDA-approved cancer drugs undergo rigorous testing to ensure safety and efficacy in treating various types of cancer. These drugs go through extensive clinical trials to demonstrate their benefits and potential side effects. Once approved by the FDA, they are available for use by healthcare providers to treat cancer patients. These drugs have significantly improved treatment outcomes for cancer patients and continue to be a vital part of cancer therapy. Healthcare providers must stay updated on FDA-approved cancer drugs to provide the best care for their patients